Observational studyClinical cancer research : an official journal of the American Association for Cancer Research2019
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in
Abstract readObservational Study
In one paragraph
Observational study in Clinical cancer research : an official journal of the American Association for Cancer Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.
- Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Guideline
- Improved polygenic risk prediction models for breast cancer subtypes in women of African ancestry.Nature genetics · 2026Article
- Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction.Israel journal of health policy research · 2026Article
- Diagnostic sensitivity of mammography and magnetic resonance imaging for ductal carcinomaChinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2025Article
- Accurate prediction of disease-risk factors from volumetric medical scans by a deep vision model pre-trained with 2D scans.Nature biomedical engineering · 2025Article
- Review
- Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing.JAMA network open · 2025Article
- Clinical genetics in breast cancer.Journal of surgical oncology · 2024Review
- The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition.Breast cancer (Tokyo, Japan) · 2024Article
- Maintaining accuracy and expanding access: evaluating the efficacy of the Botucatu Abbreviated Breast MRI Protocol.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2024Article
- Primary Prevention and Early Detection of Hereditary Breast Cancer.Breast care (Basel, Switzerland) · 2023Review
- External Evaluation of a Mammography-based Deep Learning Model for Predicting Breast Cancer in an Ethnically Diverse Population.Radiology. Artificial intelligence · 2023Article
- Article
- Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles.Nature communications · 2023Article
- The Future of Breast Cancer Research in the Survivorship Field.Oncology and therapy · 2023Review
- Surgical Management of Hereditary Breast Cancer.Genes · 2021Review
- [High-risk screening using magnetic resonance imaging].Der Radiologe · 2021Review
- Magnetic Resonance Imaging in Screening of Breast Cancer.Radiologic clinics of North America · 2021Review
- Breast Cancer Mortality among Women with aCancers · 2020Article
- A review on methods for diagnosis of breast cancer cells and tissues.Cell proliferation · 2020Review
Corrections and comments
- Commented on by
Authors and funding
30 authors at 10 institutions in 2 countries.
Rodrigo Santa Cruz Guindalini *Center for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.ORCID 0000-0002-5198-8966
Yonglan Zheng *Center for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Hiroyuki Abe *Department of Radiology, The University of Chicago, Chicago, Illinois.
Kristen WhitakerCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Toshio F YoshimatsuCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.ORCID 0000-0003-2674-8159
Tom WalshDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington.
David SchachtDepartment of Radiology, The University of Chicago, Chicago, Illinois.
Kirti KulkarniDepartment of Radiology, The University of Chicago, Chicago, Illinois.
Deepa ShethDepartment of Radiology, The University of Chicago, Chicago, Illinois.
Marion S VerpCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Angela R BradburyDepartment of Medicine, Division of Hematology-Oncology, and Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania.
Jane ChurpekCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Elias ObeidDepartment of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Jeffrey MuellerDepartment of Pathology, The University of Chicago, Chicago, Illinois.
Galina KhramtsovaCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.ORCID 0000-0001-9625-1549
Fang LiuCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Akila RaoulCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Hongyuan CaoDepartment of Public Health Sciences, The University of Chicago, Chicago, Illinois.
Iris L RomeroCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Susan HongCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois.
Robert LivingstonDepartment of Laboratory Medicine, University of Washington, Seattle, Washington.
Nora JaskowiakDepartment of Surgery, The University of Chicago, Chicago, Illinois.ORCID 0000-0003-3624-3891
Xiaoming WangComputation Institute, The University of Chicago, Chicago, Illinois.ORCID 0000-0002-6473-1297
Marcio DebiasiPUCRS School of Medicine, Porto Alegre, Rio Grande do Sul, Brazil.
Colin C PritchardDepartment of Laboratory Medicine, University of Washington, Seattle, Washington.
Mary-Claire KingDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington.
Gregory KarczmarDepartment of Radiology, The University of Chicago, Chicago, Illinois. folopade@medicine.bsd.uchicago.edu gskarczm@uchicago.edu dhuo@health.bsd.uchicago.edu.
Gillian M NewsteadDepartment of Radiology, The University of Chicago, Chicago, Illinois.
Dezheng HuoDepartment of Public Health Sciences, The University of Chicago, Chicago, Illinois. folopade@medicine.bsd.uchicago.edu gskarczm@uchicago.edu dhuo@health.bsd.uchicago.edu.
Olufunmilayo I OlopadeCenter for Clinical Cancer Genetics and Global Health, Department of Medicine, The University of Chicago, Chicago, Illinois. folopade@medicine.bsd.uchicago.edu gskarczm@uchicago.edu dhuo@health.bsd.uchicago.edu.
University of Chicago · USChicago Department of Public Health · USUniversity of Washington · USUniversity of Washington Medical Center · USFox Chase Cancer Center · USShirley Ryan AbilityLab · USUniversidade do Estado da Bahia · BRUniversidade Federal do Rio Grande do Sul · BRUniversity of Illinois Chicago · USUniversity of Pennsylvania · US
Funding
Variation in Hormone and xenobiotic metabolizing enzyme genes and breast cancerP50CA125183 · NCI · UNIVERSITY OF CHICAGO · PI COX, NANCY · 2006 to 2010
$11.3MDeveloping an Oncology Workforce for the 21st Century - Renewal 01K12CA139160 · NCI · UNIVERSITY OF CHICAGO · PI OLOPADE, OLUFUNMILAYO F., SMITH, SONALI · 2010 to 2024
$10.6MUNIVERSITY OF CHICAGO PREPR25GM066522 · NIGMS · UNIVERSITY OF CHICAGO · PI CARRILLO, ROBERT ARNULFO, RANDALL, GLENN C · 2004 to 2024
$6.7MUChicago Interdisciplinary Cancer Health Disparities SPOREP20CA233307 · NCI · UNIVERSITY OF CHICAGO · PI HUO, DEZHENG, NANDA, RITA · 2018 to 2020
$3.4MNCI NIH HHS K12 CA139160NCI NIH HHS P20 CA233307NCI NIH HHS P50 CA125183NIGMS NIH HHS R25 GM066522
Abstract
purposeTo establish a cohort of high-risk women undergoing intensive surveillance for breast cancer.
resultsBetween 2004 and 2016, we prospectively enrolled 295 women, including 157 mutation carriers (75
conclusionsBiannual MRI performed well for early detection of invasive breast cancer in genomically stratified high-risk women. No benefit was associated with annual MG screening plus biannual MRI screening.See related commentary by Kuhl and Schrading, p. 1693.
Indexed as
AdultBiopsyBRCA1 ProteinBreast NeoplasmsEarly Detection of CancerFemaleGenetic Predisposition to DiseaseHumansMagnetic Resonance ImagingMammographyMass ScreeningMiddle AgedMutationNeoplasm StagingProspective StudiesBRCA1 ProteinBRCA1 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.